Uzm. Dr. İnci Yılmaz Nakir
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
HIV Infections 10 publicationsSource: OpenAlex / PubMed MeSHView publications
- COVID-19 6 publications
- Tuberculosis 3 publications
- Hepatitis B 3 publications
- Acquired Immunodeficiency Syndrome 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
- Institutionİstanbul Haseki Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workHIV InfectionsExtracted from 10 publications · Model version —From source
- Publications28 publicationsORCID, OpenAlex, Europe PMCFrom source
- ORCID0000-0002-2987-1534ORCIDFrom source
- Last synchronised5 November 2026 08:56https://hasekieah.saglik.gov.tr/TR-659723/doktorlar.html#inci-yilmaz-nakirsaglik.gov.tr
Scientific work
Publications on HIV Infections
-
Clinical Determinants of 30-Day Mortality in Candidemia: Antifungal Susceptibility and Treatment Patterns in a 10-Year Cohort
Antibiotics, 2026
DOI 10.3390/antibiotics15050438 PMID 42192660 Open-access full textSource: ORCID
-
Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis
Minerva Gastroenterology, 2026
DOI 10.23736/s2724-5985.26.03992-6 PMID 41848668 1 citation (OpenAlex) Source: OpenAlex
-
Has the Expected Shift in HIV-Related Cancers Occurred? Findings from a Long-Term HIV Cohort in Turkey
Journal of clinical medicine, 2026
DOI 10.3390/jcm15124818 PMID 42355986 Open-access full textSource: Europe PMC
-
Toxoplasma Gondii IGG seroprevalence among individuals living with HIV: An 18-year single-center retrospective evaluation
Journal of Infection and Public Health, 2026
DOI 10.1016/j.jiph.2026.103234 PMID 42068815 Open-access full textSource: ORCID
-
Bruselloz İnsidansının Düşük Olduğu Bir Bölgede İzlenen Hastaların Değerlendirilmesi
Harran Üniversitesi Tıp Fakültesi Dergisi, 2025
DOI 10.35440/hutfd.1657068 Open-access full textSource: ORCID
-
Evaluation of the in vivo Antifungal Effects of Ankaferd Blood Stopper in a Neutropenic Rat Model of Systemic Candidiasis
Turkish Journal of Internal Medicine, 2025
DOI 10.46310/tjim.1723416 Open-access full textSource: ORCID
-
Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014–2024) ClinSurv HIV cohort: A large case series
PLOS One, 2025
DOI 10.1371/journal.pone.0329267 PMID 40748951 Open-access full textSource: ORCID
-
Efficacy of tenofovir alafenamide- or tenofovir disoproxil fumarate-containing regimens in adults with treatment-naïve HIV-hepatitis B co-infection
International Journal of STD & AIDS, 2025
DOI 10.1177/09564624251352345 PMID 40532233 1 citation (Europe PMC) Source: ORCID
-
Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapy
Viruses, 2025
DOI 10.3390/v17111436 PMID 41305459 Open-access full textSource: ORCID
-
Risk Factors for Major Adverse Cardiovascular Events in Antiretroviral Therapy-Treated People with HIV: A Long-Term Cohort Study in Turkey
AIDS Patient Care and STDs, 2025
DOI 10.1177/10872914251359817 PMID 40681313 1 citation (Europe PMC) Source: ORCID